Wei, Jie
Zhang, Weiya
Doherty, Michael
Wallace, Zachary S.
Sparks, Jeffrey A.
Lu, Na
Li, Xiaoxiao
Zeng, Chao
Lei, Guanghua
Zhang, Yuqing
Article History
Received: 9 April 2022
Accepted: 20 February 2023
First Online: 28 February 2023
Declarations
:
: This study received approval from the medical ethical committee at Xiangya Hospital (2018091077), with waiver of informed consent. This study was approved by the IMRD Scientific Review Committee (22SRC008).
: Not applicable. This work uses de-identified data provided by patients as a part of their routine primary care.
: Dr. Sparks has received research support from Bristol Myers Squibb and performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum, and Pfizer unrelated to this work. No conflict of interest for other authors.